Coronary Artery Disease Clinical Trials in Durham, North Carolina

8 studies are recruiting for coronary artery disease in Durham, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Product Surveillance Registry

   The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

   Stage

   Not phased

   Ages

   Any age

   Site

   Research site, Durham, North Carolina

   Locations

   401 in total

   Run by

   Medtronic

   See if you can join NCT01524276 on ClinicalTrials.gov

2. Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

   This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD. Pa…

   Stage

   Phase 2

   Ages

   18 to 85

   Site

   Duke University, Durham, North Carolina

   Locations

   14 in total

   Run by

   XyloCor Therapeutics, Inc.

   See if you can join NCT07048808 on ClinicalTrials.gov

3. REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

   This is a research study in women to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an o…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Duke University, Durham, North Carolina

   Locations

   18 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT06399692 on ClinicalTrials.gov

4. REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

   This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Duke University, Durham, North Carolina

   Locations

   18 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT06399705 on ClinicalTrials.gov

5. ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

   The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Duke University Hospital, Durham, North Carolina

   Locations

   19 in total

   Run by

   Emory University

   See if you can join NCT07559903 on ClinicalTrials.gov

6. CTSN Embolic Protection Trial

   This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

   Stage

   Not phased

   Ages

   60 and older

   Site

   Duke University, Durham, North Carolina

   Locations

   28 in total

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT06027788 on ClinicalTrials.gov

7. The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

   Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with heart disease undergoing major surgery are at increased risk of complications after surgery, including heart attack, stroke, and death. The p…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   Durham VA Medical Center, Durham, NC, Durham, North Carolina

   Locations

   9 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT05618353 on ClinicalTrials.gov

8. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

   The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Duke University, Durham, North Carolina

   Locations

   146 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT04124120 on ClinicalTrials.gov